18 June 2013
Keywords: sanofi, launches, apidra, canada, french, drug, major
Article | 02 March 2009
French drug major Sanofi-Aventis has launched Apidra (insulin glulisine), for the treatment of type 1 and type 2 diabetes, on the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
17 June 2013
© 2013 thepharmaletter.com